Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
Intrinsic Value
Hangzhou Coco Healthcare Products Co., Ltd. engages in the design, research, development, production, and sale of disposable hygiene products. [ Read More ]
The intrinsic value of one
Hangzhou Coco Healthcare Products Co Ltd
stock under the Base Case scenario is
12.81
CNY.
Compared to the current market price of 8.63 CNY,
Hangzhou Coco Healthcare Products Co Ltd
is
Undervalued by 33%.
Hangzhou Coco Healthcare Products Co Ltd's market capitalization is 2.3B CNY.
Hangzhou Coco Healthcare Products Co Ltd stock price is 8.63 CNY.
Hangzhou Coco Healthcare Products Co Ltd stock price (8.63 CNY) is 33% less than its Intrinsic Value (12.81 CNY).
Hangzhou Coco Healthcare Products Co Ltd stock price (8.63 CNY) is 31% less than its DCF Value (12.46 CNY). Open DCF Valuation
Hangzhou Coco Healthcare Products Co Ltd stock price (8.63 CNY) is 34% less than its Relative Value (13.15 CNY). Open Relative Valuation
Hangzhou Coco Healthcare Products Co Ltd has upside potential of 75% compared to the average analyst price target.
Open Wall St Estimates
Hangzhou Coco Healthcare Products Co Ltd's Revenue has dropped by 2% over the past 12 months.
Hangzhou Coco Healthcare Products Co Ltd has positive Gross Profit for the last twelve months.
Hangzhou Coco Healthcare Products Co Ltd's Revenue is forecast to grow at a rate of 16% per year over the next 3 years.
Hangzhou Coco Healthcare Products Co Ltd has positive three-year average ROE (Return on Equity): 5%. The company is efficient at transforming stockholders' equity into net income.
Hangzhou Coco Healthcare Products Co Ltd has negative Operating Income for the last twelve months.
Hangzhou Coco Healthcare Products Co Ltd has negative Net Income for the last twelve months.
Hangzhou Coco Healthcare Products Co Ltd's ROE (Return on Equity) for the past 12 months is negative and is equal to -2%.
Hangzhou Coco Healthcare Products Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 4%. The company is not efficient at using invested capital to generate operating income.
Hangzhou Coco Healthcare Products Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -6%.
Hangzhou Coco Healthcare Products Co Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 25% to -2%.
Hangzhou Coco Healthcare Products Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 23% to -6%.
Hangzhou Coco Healthcare Products Co Ltd has positive Free Cash Flow for the last twelve months.
Hangzhou Coco Healthcare Products Co Ltd's short-term assets (1B CNY) exceed its short-term liabilties (422m CNY).
Hangzhou Coco Healthcare Products Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (699m CNY) than debt (270m CNY).
Hangzhou Coco Healthcare Products Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.2.
Hangzhou Coco Healthcare Products Co Ltd's long-term assets (2B CNY) exceed its long-term liabilties (561m CNY).
Hangzhou Coco Healthcare Products Co Ltd's Altman Z-Score is very high and is equal to 4.64.
Valuation Backtest
Hangzhou Coco Healthcare Products Co Ltd
Run backtest to discover the historical profit from buying and selling
Hangzhou Coco Healthcare Products Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Hangzhou Coco Healthcare Products Co Ltd
Balance Sheet Decomposition
Hangzhou Coco Healthcare Products Co Ltd
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 699m |
| Receivables | 242.9m |
| Other Current Assets | 188.1m |
| Non-Current Assets | 805.9m |
| Long-Term Investments | 6.7m |
| PP&E | 686.6m |
| Intangibles | 83.7m |
| Other Non-Current Assets | 29m |
| Current Liabilities | 421.8m |
| Accounts Payable | 130.3m |
| Accrued Liabilities | 15.8m |
| Short-Term Debt | 256.2m |
| Other Current Liabilities | 19.5m |
| Non-Current Liabilities | 139.7m |
| Long-Term Debt | 13.3m |
| Other Non-Current Liabilities | 126.4m |
Earnings Waterfall
Hangzhou Coco Healthcare Products Co Ltd
|
Revenue
|
1.1B
CNY
|
|
Cost of Revenue
|
-951.7m
CNY
|
|
Gross Profit
|
192.2m
CNY
|
|
Operating Expenses
|
-250m
CNY
|
|
Operating Income
|
-57.8m
CNY
|
|
Other Expenses
|
27.1m
CNY
|
|
Net Income
|
-30.7m
CNY
|
Free Cash Flow Analysis
Hangzhou Coco Healthcare Products Co Ltd
Profitability Score
Profitability Due Diligence
Hangzhou Coco Healthcare Products Co Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Hangzhou Coco Healthcare Products Co Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hangzhou Coco Healthcare Products Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Hangzhou Coco Healthcare Products Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hangzhou Coco Healthcare Products Co Ltd
According to Wall Street analysts, the average 1-year price target for
Hangzhou Coco Healthcare Products Co Ltd
is 15.1 CNY
with a low forecast of 14.95 CNY and a high forecast of 15.54 CNY.
Shareholder Return
Price
Hangzhou Coco Healthcare Products Co Ltd
| Average Annual Return | -31.09% |
| Standard Deviation of Annual Returns | 5.23% |
| Max Drawdown | -80% |
| Market Capitalization | 2.3B CNY |
| Shares Outstanding | 271 860 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Hangzhou Coco Healthcare Products Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Hangzhou Coco Healthcare Products Co., Ltd. engages in the design, research, development, production, and sale of disposable hygiene products. The company is headquartered in Hangzhou, Zhejiang and currently employs 799 full-time employees. The company went IPO on 2021-06-17. The firm's main products include baby care products, adult incontinence products and pet hygiene products and masks. Among them, adult incontinence products include adult diapers, adult pull-up pants, adult diapers, nursing pads, maternity towels, menstrual pants and absorbent towels. Baby care products mainly include baby diapers, baby pull-up pants and baby diapers. Pet hygiene products include pet diapers and pet care pads. The firm distributes its products both in the domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Hangzhou Coco Healthcare Products Co Ltd
stock under the Base Case scenario is
12.81
CNY.
Compared to the current market price of 8.63 CNY,
Hangzhou Coco Healthcare Products Co Ltd
is
Undervalued by 33%.
You don't have any saved screeners yet
